ID   REG3A_HUMAN             Reviewed;         175 AA.
AC   Q06141;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   03-AUG-2022, entry version 181.
DE   RecName: Full=Regenerating islet-derived protein 3-alpha;
DE            Short=REG-3-alpha;
DE   AltName: Full=Hepatointestinal pancreatic protein;
DE            Short=HIP/PAP;
DE   AltName: Full=Human proislet peptide;
DE   AltName: Full=Pancreatitis-associated protein 1;
DE   AltName: Full=Regenerating islet-derived protein III-alpha;
DE            Short=Reg III-alpha;
DE   Contains:
DE     RecName: Full=Regenerating islet-derived protein 3-alpha 16.5 kDa form;
DE   Contains:
DE     RecName: Full=Regenerating islet-derived protein 3-alpha 15 kDa form;
DE   Flags: Precursor;
GN   Name=REG3A; Synonyms=HIP, PAP, PAP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Pancreas, and Small intestine;
RX   PubMed=7679928; DOI=10.1016/0167-4781(93)90290-t;
RA   Itoh T., Teraoka H.;
RT   "Cloning and tissue-specific expression of cDNAs for the human and mouse
RT   homologues of rat pancreatitis-associated protein (PAP).";
RL   Biochim. Biophys. Acta 1172:184-186(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Pancreas;
RX   PubMed=1469087; DOI=10.1172/jci116115;
RA   Orelle B., Keim V., Masciotra L., Dagorn J.-C., Iovanna J.-L.;
RT   "Human pancreatitis-associated protein. Messenger RNA cloning and
RT   expression in pancreatic diseases.";
RL   J. Clin. Invest. 90:2284-2291(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=1325291;
RA   Lasserre C., Christa L., Simon M.T., Vernier P., Brechot C.;
RT   "A novel gene (HIP) activated in human primary liver cancer.";
RL   Cancer Res. 52:5089-5095(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RX   PubMed=8188210; DOI=10.1006/geno.1994.1019;
RA   Dusetti N.J., Frigerio J.-M., Fox M.F., Swallow D.M., Dagorn J.-C.,
RA   Iovanna J.L.;
RT   "Molecular cloning, genomic organization, and chromosomal localization of
RT   the human pancreatitis-associated protein (PAP) gene.";
RL   Genomics 19:108-114(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8076648; DOI=10.1111/j.1432-1033.1994.tb19991.x;
RA   Lasserre C., Simon M.T., Ishikawa H., Diriong S., Nguyen V.C., Christa L.,
RA   Vernier P., Brechot C.;
RT   "Structural organization and chromosomal localization of a human gene
RT   (HIP/PAP) encoding a C-type lectin overexpressed in primary liver cancer.";
RL   Eur. J. Biochem. 224:29-38(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF N-TERMINUS, AND PROTEOLYTIC PROCESSING.
RX   PubMed=19254208; DOI=10.1042/bj20090005;
RA   Medveczky P., Szmola R., Sahin-Toth M.;
RT   "Proteolytic activation of human pancreatitis-associated protein is
RT   required for peptidoglycan binding and bacterial aggregation.";
RL   Biochem. J. 420:335-343(2009).
RN   [8]
RP   FUNCTION, AND MANNAN- AND PEPTIDOGLYCAN-BINDING.
RX   PubMed=16931762; DOI=10.1126/science.1127119;
RA   Cash H.L., Whitham C.V., Behrendt C.L., Hooper L.V.;
RT   "Symbiotic bacteria direct expression of an intestinal bactericidal
RT   lectin.";
RL   Science 313:1126-1130(2006).
RN   [9]
RP   TISSUE SPECIFICITY, AND INTERACTION WITH EXTL3.
RX   PubMed=22727489; DOI=10.1016/j.immuni.2012.04.010;
RA   Lai Y., Li D., Li C., Muehleisen B., Radek K.A., Park H.J., Jiang Z.,
RA   Li Z., Lei H., Quan Y., Zhang T., Wu Y., Kotol P., Morizane S., Hata T.R.,
RA   Iwatsuki K., Tang C., Gallo R.L.;
RT   "The antimicrobial protein REG3A regulates keratinocyte proliferation and
RT   differentiation after skin injury.";
RL   Immunity 37:74-84(2012).
RN   [10]
RP   STRUCTURE BY NMR, MOTIF EPN, AND MUTAGENESIS OF GLU-114 AND GLU-118.
RX   PubMed=20382864; DOI=10.1073/pnas.0909449107;
RA   Lehotzky R.E., Partch C.L., Mukherjee S., Cash H.L., Goldman W.E.,
RA   Gardner K.H., Hooper L.V.;
RT   "Molecular basis for peptidoglycan recognition by a bactericidal lectin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:7722-7727(2010).
CC   -!- FUNCTION: Bactericidal C-type lectin which acts exclusively against
CC       Gram-positive bacteria and mediates bacterial killing by binding to
CC       surface-exposed carbohydrate moieties of peptidoglycan. Regulates
CC       keratinocyte proliferation and differentiation after skin injury via
CC       activation of EXTL3-PI3K-AKT signaling pathway.
CC       {ECO:0000269|PubMed:16931762}.
CC   -!- SUBUNIT: Interacts with EXTL3. {ECO:0000269|PubMed:22727489}.
CC   -!- INTERACTION:
CC       Q06141; Q99750: MDFI; NbExp=3; IntAct=EBI-10223932, EBI-724076;
CC       Q06141; Q06141: REG3A; NbExp=2; IntAct=EBI-10223932, EBI-10223932;
CC   -!- SUBCELLULAR LOCATION: Secreted. Note=Found in the apical region of
CC       pancreatic acinar cells.
CC   -!- TISSUE SPECIFICITY: Highly expressed in epidermal keratinocytes of
CC       psoriasis patients (at protein level). Constitutively expressed in
CC       intestine. Low expression is found in healthy pancreas. Overexpressed
CC       during the acute phase of pancreatitis and in some patients with
CC       chronic pancreatitis. {ECO:0000269|PubMed:1469087,
CC       ECO:0000269|PubMed:22727489}.
CC   -!- INDUCTION: Appears in pancreatic juice after induction of pancreatic
CC       inflammation.
CC   -!- DOMAIN: The EPN motif is essential for recognition of the peptidoglycan
CC       carbohydrate backbone and for efficient bacterial killing with Glu-114
CC       playing a key role in peptidoglycan binding and bactericidal activity.
CC   -!- PTM: Proteolytic processing by trypsin removes an inhibitory N-terminal
CC       propeptide and is essential for peptidoglycan binding and antibacterial
CC       activity. {ECO:0000269|PubMed:19254208}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Pancreatitis-associated protein 1;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Ctlect_256";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D13510; BAA02728.1; -; mRNA.
DR   EMBL; M84337; AAA36415.1; -; mRNA.
DR   EMBL; S51768; AAB24642.1; -; mRNA.
DR   EMBL; X68641; CAA48605.1; -; mRNA.
DR   EMBL; L15533; AAA60020.1; -; Genomic_DNA.
DR   EMBL; BC036776; AAH36776.1; -; mRNA.
DR   CCDS; CCDS1965.1; -.
DR   PIR; A49616; A49616.
DR   RefSeq; NP_002571.1; NM_002580.2.
DR   RefSeq; NP_620354.1; NM_138937.2.
DR   RefSeq; NP_620355.1; NM_138938.2.
DR   PDB; 1UV0; X-ray; 1.78 A; A=27-175.
DR   PDB; 2GO0; NMR; -; A=39-175.
DR   PDB; 4MTH; X-ray; 1.47 A; A=38-175.
DR   PDBsum; 1UV0; -.
DR   PDBsum; 2GO0; -.
DR   PDBsum; 4MTH; -.
DR   AlphaFoldDB; Q06141; -.
DR   SMR; Q06141; -.
DR   BioGRID; 111103; 15.
DR   DIP; DIP-60688N; -.
DR   IntAct; Q06141; 4.
DR   STRING; 9606.ENSP00000377456; -.
DR   MEROPS; I63.002; -.
DR   TCDB; 1.C.111.1.2; the regiiiGama (regiiiGama) family.
DR   UniLectin; Q06141; -.
DR   BioMuta; REG3A; -.
DR   DMDM; 464341; -.
DR   EPD; Q06141; -.
DR   jPOST; Q06141; -.
DR   MassIVE; Q06141; -.
DR   PaxDb; Q06141; -.
DR   PeptideAtlas; Q06141; -.
DR   PRIDE; Q06141; -.
DR   ProteomicsDB; 58418; -.
DR   Antibodypedia; 16859; 544 antibodies from 34 providers.
DR   DNASU; 5068; -.
DR   Ensembl; ENST00000305165.3; ENSP00000304311.2; ENSG00000172016.16.
DR   Ensembl; ENST00000393878.5; ENSP00000377456.1; ENSG00000172016.16.
DR   Ensembl; ENST00000409839.7; ENSP00000386630.3; ENSG00000172016.16.
DR   GeneID; 5068; -.
DR   KEGG; hsa:5068; -.
DR   MANE-Select; ENST00000305165.3; ENSP00000304311.2; NM_002580.3; NP_002571.1.
DR   CTD; 5068; -.
DR   DisGeNET; 5068; -.
DR   GeneCards; REG3A; -.
DR   HGNC; HGNC:8601; REG3A.
DR   HPA; ENSG00000172016; Group enriched (intestine, pancreas).
DR   MIM; 167805; gene.
DR   neXtProt; NX_Q06141; -.
DR   OpenTargets; ENSG00000172016; -.
DR   PharmGKB; PA32931; -.
DR   VEuPathDB; HostDB:ENSG00000172016; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   GeneTree; ENSGT00940000162300; -.
DR   HOGENOM; CLU_049894_18_0_1; -.
DR   InParanoid; Q06141; -.
DR   OMA; CYLYVPQ; -.
DR   OrthoDB; 1509611at2759; -.
DR   PhylomeDB; Q06141; -.
DR   PathwayCommons; Q06141; -.
DR   Reactome; R-HSA-6803157; Antimicrobial peptides.
DR   SignaLink; Q06141; -.
DR   BioGRID-ORCS; 5068; 6 hits in 1055 CRISPR screens.
DR   ChiTaRS; REG3A; human.
DR   EvolutionaryTrace; Q06141; -.
DR   GeneWiki; REG3A; -.
DR   GenomeRNAi; 5068; -.
DR   Pharos; Q06141; Tbio.
DR   PRO; PR:Q06141; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q06141; protein.
DR   Bgee; ENSG00000172016; Expressed in ileal mucosa and 113 other tissues.
DR   ExpressionAtlas; Q06141; baseline and differential.
DR   Genevisible; Q06141; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0030246; F:carbohydrate binding; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0070492; F:oligosaccharide binding; IBA:GO_Central.
DR   GO; GO:0042834; F:peptidoglycan binding; IBA:GO_Central.
DR   GO; GO:0038023; F:signaling receptor activity; IBA:GO_Central.
DR   GO; GO:0006953; P:acute-phase response; IEA:UniProtKB-KW.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IBA:GO_Central.
DR   GO; GO:0044278; P:cell wall disruption in another organism; IBA:GO_Central.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; TAS:ProtInc.
DR   GO; GO:0045617; P:negative regulation of keratinocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IBA:GO_Central.
DR   GO; GO:0010838; P:positive regulation of keratinocyte proliferation; ISS:UniProtKB.
DR   GO; GO:0090303; P:positive regulation of wound healing; ISS:UniProtKB.
DR   GO; GO:0043434; P:response to peptide hormone; IBA:GO_Central.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR016187; CTDL_fold.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acute phase; Antimicrobial; Direct protein sequencing;
KW   Disulfide bond; Inflammatory response; Lectin; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000250"
FT   CHAIN           27..175
FT                   /note="Regenerating islet-derived protein 3-alpha 16.5 kDa
FT                   form"
FT                   /id="PRO_0000017429"
FT   PROPEP          27..37
FT                   /evidence="ECO:0000269|PubMed:19254208"
FT                   /id="PRO_0000422741"
FT   CHAIN           38..175
FT                   /note="Regenerating islet-derived protein 3-alpha 15 kDa
FT                   form"
FT                   /id="PRO_0000422742"
FT   DOMAIN          47..172
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   MOTIF           114..116
FT                   /note="EPN"
FT   DISULFID        40..51
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DISULFID        68..171
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DISULFID        146..163
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   MUTAGEN         114
FT                   /note="E->Q: Reduces peptidoglycan binding and
FT                   antibacterial activity."
FT                   /evidence="ECO:0000269|PubMed:20382864"
FT   MUTAGEN         118
FT                   /note="E->Q: Reduces antibacterial activity but no effect
FT                   on peptidoglycan binding."
FT                   /evidence="ECO:0000269|PubMed:20382864"
FT   CONFLICT        173..175
FT                   /note="FTD -> VH (in Ref. 2; AAA36415)"
FT                   /evidence="ECO:0000305"
FT   STRAND          44..47
FT                   /evidence="ECO:0007829|PDB:4MTH"
FT   STRAND          50..59
FT                   /evidence="ECO:0007829|PDB:4MTH"
FT   HELIX           61..68
FT                   /evidence="ECO:0007829|PDB:4MTH"
FT   HELIX           82..92
FT                   /evidence="ECO:0007829|PDB:4MTH"
FT   STRAND          100..107
FT                   /evidence="ECO:0007829|PDB:4MTH"
FT   TURN            109..112
FT                   /evidence="ECO:0007829|PDB:4MTH"
FT   STRAND          114..116
FT                   /evidence="ECO:0007829|PDB:2GO0"
FT   TURN            123..125
FT                   /evidence="ECO:0007829|PDB:2GO0"
FT   STRAND          133..135
FT                   /evidence="ECO:0007829|PDB:4MTH"
FT   HELIX           137..139
FT                   /evidence="ECO:0007829|PDB:4MTH"
FT   STRAND          140..142
FT                   /evidence="ECO:0007829|PDB:4MTH"
FT   STRAND          145..150
FT                   /evidence="ECO:0007829|PDB:4MTH"
FT   HELIX           151..153
FT                   /evidence="ECO:0007829|PDB:4MTH"
FT   STRAND          157..161
FT                   /evidence="ECO:0007829|PDB:4MTH"
FT   STRAND          167..173
FT                   /evidence="ECO:0007829|PDB:4MTH"
SQ   SEQUENCE   175 AA;  19395 MW;  C51149FAC22EB68C CRC64;
     MLPPMALPSV SWMLLSCLML LSQVQGEEPQ RELPSARIRC PKGSKAYGSH CYALFLSPKS
     WTDADLACQK RPSGNLVSVL SGAEGSFVSS LVKSIGNSYS YVWIGLHDPT QGTEPNGEGW
     EWSSSDVMNY FAWERNPSTI SSPGHCASLS RSTAFLRWKD YNCNVRLPYV CKFTD
//
